MedPath

low dose intravenous and caudal dexamethasone in caudal anesthesia

Phase 2
Conditions
prospective study
Registration Number
JPRN-UMIN000043810
Lead Sponsor
Minia University, Faculty of medicine anesthesia and intensive care department
Brief Summary

Dexamethasone promotes the analgesic effect of caudal bupivacaine either if combined with bupivacaine caudally or via (iv) route compared to the control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

coagulopathies, infection at the block targeted site, or with known allergy to any of the drugs included in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the duration of the postoperative caudal analgesia and severity of postoperative pain
Secondary Outcome Measures
NameTimeMethod
umber of rescue analgesic doses, residual motor block, and side effects like nausea and vomiting
© Copyright 2025. All Rights Reserved by MedPath